Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geovax Labs
(NQ:
GOVX
)
2.700
+0.090 (+3.45%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geovax Labs
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
May 17, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024
May 15, 2024
GOVX stock results show that Geovax Labs beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
Presented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate
Via
TheNewswire.com
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
May 09, 2024
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.
Via
Benzinga
GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress
March 28, 2024
Via
NewMediaWire
Exposures
COVID-19
GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the 36th Annual Roth Conference
March 08, 2024
Via
Investor Brand Network
Exposures
COVID-19
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
March 06, 2024
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines
Via
NewMediaWire
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
May 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
May 07, 2024
GeoVax to Host Conference Call at 4:30 PM ET
Via
TheNewswire.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 05, 2024
Via
Benzinga
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
April 04, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Geovax Labs: Q4 Earnings Insights
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Earnings Outlook For Geovax Labs
February 28, 2024
Via
Benzinga
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
April 04, 2024
Presentation Made During the 24th Annual World Vaccine Congress
Via
TheNewswire.com
Exposures
COVID-19
GeoVax to Present at the 36th Annual Roth Conference
March 12, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
February 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
February 23, 2024
The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
February 22, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
February 22, 2024
GeoVax to Host Conference Call at 4:30 PM ET
Via
TheNewswire.com
GeoVax to Present at the 2024 BIO CEO & Investor Conference
February 19, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the 2024 BIO CEO & Investor Conference
February 19, 2024
ATLANTA, GA - (NewMediaWire) - February 19, 2024 - Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today...
Via
TheNewswire.com
GeoVax Announces Multiple Patent Issuances and Allowances
February 13, 2024
Intellectual Property Assets Strengthened for Cancer Immunotherapy Program
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
February 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
February 06, 2024
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
Via
TheNewswire.com
Exposures
COVID-19
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
January 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
January 29, 2024
ATLANTA, GA - (NewMediaWire) - January 29, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
Via
TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 24, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 24, 2024
It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.